We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
326
Amarin Corp
AMRN
$297M
| $7.76K | ﹤0.01% |
259
+55
| +27% | +$1.93K |
|
327
Fate Therapeutics
FATE
$317M
| $7.58K | ﹤0.01% |
1,330
+343
| +35% | +$2.07K |
|
328
Diamondback Energy
FANG
$56.2B
| $7.57K | ﹤0.01% |
+56
| New | +$7.8K |
|
329
4D Molecular Therapeutics
FDMT
$621M
| $7.55K | ﹤0.01% |
439
+110
| +33% | +$2.14K |
|
|
ICPT
330
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.53K | ﹤0.01% |
561
+140
| +33% | +$2.42K |
|
|
HLVX
331
DELISTED
HilleVax
HLVX
| $7.47K | ﹤0.01% |
452
+113
| +33% | +$1.81K |
|
|
BCYC
332
Bicycle Therapeutics
BCYC
$284M
| $7.42K | ﹤0.01% |
349
+90
| +35% | +$2.26K |
|
333
Aclaris Therapeutics
ACRS
$860M
| $7.3K | ﹤0.01% |
903
+225
| +33% | +$2.86K |
|
334
Coherus Oncology
CHRS
$181M
| $7.21K | ﹤0.01% |
1,054
+264
| +33% | +$2.05K |
|
335
eBay
EBAY
$45.5B
| $7.19K | ﹤0.01% |
+162
| New | +$7.42K |
|
|
LKFT
336
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $7.03K | ﹤0.01% |
182
+46
| +34% | +$1.89K |
|
337
Alector
ALEC
$240M
| $6.96K | ﹤0.01% |
1,125
+285
| +34% | +$2.32K |
|
338
MaxCyte
MXCT
$136M
| $6.84K | ﹤0.01% |
1,382
+345
| +33% | +$1.7K |
|
339
Editas Medicine
EDIT
$436M
| $6.78K | ﹤0.01% |
935
+237
| +34% | +$2.11K |
|
|
ITOS
340
DELISTED
iTeos Therapeutics
ITOS
| $6.56K | ﹤0.01% |
482
+121
| +34% | +$2.17K |
|
341
Evolus
EOLS
$536M
| $6.45K | ﹤0.01% |
762
+191
| +33% | +$1.73K |
|
342
Arbutus Biopharma
ABUS
$907M
| $6.42K | ﹤0.01% |
2,120
+530
| +33% | +$1.5K |
|
|
NSTG
343
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.28K | ﹤0.01% |
634
+160
| +34% | +$1.58K |
|
344
Lexicon Pharmaceuticals
LXRX
$1.05B
| $6.21K | ﹤0.01% |
2,557
+639
| +33% | +$1.46K |
|
|
MRSN
345
DELISTED
Mersana Therapeutics
MRSN
| $6.01K | ﹤0.01% |
59
+18
| +44% | +$2.53K |
|
346
Karyopharm Therapeutics
KPTI
$46M
| $5.97K | ﹤0.01% |
102
+47
| +85% | +$2.32K |
|
347
MacroGenics
MGNX
$256M
| $5.97K | ﹤0.01% |
833
+209
| +33% | +$1.26K |
|
348
Procter & Gamble
PG
$335B
| $5.95K | ﹤0.01% |
40
| – | – |
|
349
HUTCHMED
HCM
$2.13B
| $5.92K | ﹤0.01% |
455
+80
| +21% | +$1.31K |
|
350
Wave Life Sciences
WVE
$1.03B
| $5.74K | ﹤0.01% |
1,325
+442
| +50% | +$2.02K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.